Idiopathic Urticaria
📧 Sign up to get email alerts when something new happens for Idiopathic Urticaria.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS other · 2026-03-20Clinical Trial Update: Autologous Whole Blood Therapy in Chronic Idiopathic Urticaria Patients. [Phase 3]
Phase 3 clinical trial evaluating Autologous Whole Blood Therapy for chronic idiopathic urticaria, sponsored by Cairo University, currently …
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: Study Evaluating the Efficacy and Safety of Povorcitinib in Adults With Chronic Spontaneous Urticaria [Phase 2]
Phase 2 clinical trial update reporting efficacy and safety data for povorcitinib in adults with chronic spontaneous urticaria; results comp…
-
FDA approval · 2026-01-07FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Supplemental Application (Marlex Pharmaceuticals Inc)
FDA approved a supplemental application for levocetirizine dihydrochloride from Marlex Pharmaceuticals Inc., updating the approved generic p…
-
FDA approval · 2025-11-25FDA Approved: CETIRIZINE HYDROCHLORIDE — Supplemental Application (BAJAJ MEDICAL, LLC)
FDA approved a supplemental application for cetirizine hydrochloride from Bajaj Medical, LLC, authorizing continued marketing of the generic…
-
CLINICAL_TRIALS trial_result · 2025-10-07Clinical Trial Update: Study to Compare Efficacy and Safety of TEV-45779 With XOLAIR (Omalizumab) in Adults With Chronic Idiopathic Urticaria [Phase 3]
Phase 3 trial comparing TEV-45779 with Xolair (omalizumab) in adults with chronic idiopathic urticaria has completed and posted results on 2…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-07-17FDA Approved: CETIRIZINE HYDROCHLORIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for cetirizine hydrochloride submitted by Rising Pharma Holdings, Inc. The approval relates to chang…
-
FDA approval · 2025-07-11FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for levocetirizine dihydrochloride (generic) submitted by Chartwell RX, LLC.
-
FDA approval · 2025-07-11FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Supplemental Application (Marlex Pharmaceuticals Inc)
FDA approved a supplemental application for Levocetirizine dihydrochloride from Marlex Pharmaceuticals Inc, granting regulatory authorizatio…
-
FDA approval · 2025-07-11FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for levocetirizine dihydrochloride from Glenmark, indicating an approved modification to an existing…
-
FDA approval · 2025-07-11FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Supplemental Application (Dr.Reddy's laboratories Ltd.)
The FDA approved a supplemental application for levocetirizine dihydrochloride from Dr. Reddy's Laboratories, indicating an FDA regulatory a…
-
FDA approval · 2025-07-11FDA Approved: CETIRIZINE HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for cetirizine hydrochloride from Amneal Pharmaceuticals LLC, authorizing modifications to the produ…
-
FDA approval · 2025-07-11FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for levocetirizine dihydrochloride from Macleods Pharmaceuticals Limited.
-
FDA approval · 2025-07-11FDA Approved: CETIRIZINE HYDROCHLORIDE ORAL SOLUTION — Supplemental Application (APOZEAL PHARMACEUTICALS INC)
FDA approved a supplemental application for cetirizine hydrochloride oral solution from Apozeal Pharmaceuticals Inc, expanding labeling for …
-
FDA approval · 2025-07-11FDA Approved: CETIRIZINE HYDROCHLORIDE — Supplemental Application (Heritage Pharma Labs Inc. d/b/a Avet Pharmaceuticals Labs Inc.)
FDA approved a supplemental application for cetirizine hydrochloride, adding an oral solution dosage form for this generic product (Heritage…
-
FDA approval · 2025-07-11FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Supplemental Application (Vensun Pharmaceuticals, Inc.)
FDA approves a supplemental application for Levocetirizine dihydrochloride from Vensun Pharmaceuticals, Inc., updating the approved product …
-
FDA approval · 2025-07-11FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved a supplemental application for levocetirizine dihydrochloride from Padagis Israel Pharmaceuticals Ltd, indicating a regulatory …
-
FDA approval · 2025-07-11FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Supplemental Application (Camber Pharmaceuticals, Inc.)
The FDA approved Camber Pharmaceuticals' supplemental application to market a generic levocetirizine dihydrochloride product. The product is…
-
FDA approval · 2025-06-13FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Supplemental Application (Marlex Pharmaceuticals Inc)
FDA approved a supplemental application for Levocetirizine Dihydrochloride from Marlex Pharmaceuticals Inc.
-
FDA approval · 2025-06-10FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for levocetirizine dihydrochloride from Chartwell RX, LLC.
-
FDA approval · 2025-04-17FDA Approved: CLARITIN CHEWABLE GRAPE AND BUBBLEGUM — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application to introduce Claritin Chewable Grape and Bubblegum (loratadine) by Bayer HealthCare LLC. This approv…
-
FDA approval · 2025-04-03FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Supplemental Application (Dr. Reddy's Laboratories Inc.)
FDA approved a supplemental application for levocetirizine dihydrochloride (Dr. Reddy's Laboratories Inc.), confirming the generic's labelin…
-
CLINICAL_TRIALS trial_result · 2025-02-05Clinical Trial Update: Study to Compare Efficacy Safety and Immunogenicity of ADL-018 With XOLAIR (Omalizumab) in Adults With Chronic Idiopathic Urticaria [Phase 3]
Phase 3 study comparing ADL-018 with XOLAIR (Omalizumab) in adults with Chronic Idiopathic Urticaria has completed. The trial evaluated effi…
-
FDA approval · 2024-11-21FDA Approved: LORATADINE 10 MG — Original Application (TIME CAP LABORATORIES, INC.)
FDA approved Time Cap Laboratories, Inc.'s loratadine 10 mg tablets via an original ANDA, establishing a generic version of the antihistamin…
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: Safety of Desloratadine in Children With Allergy Sensitivity and Chronic Hives, Who Are Poor Metabolizers of Desloratadine (Study P02994) [Phase 3]
Phase 3 trial evaluating the safety of desloratadine in children with allergy sensitivity and chronic hives who are poor metabolizers of des…
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: A Comparison of Aerius Continuous Treatment Versus Aerius PRN for Chronic Idiopathic Urticaria (Study P03147) [Phase 4]
Phase 4 trial comparing continuous dosing of Aerius (cetirizine) to as-needed dosing in chronic idiopathic urticaria. The study has complete…